Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

Arthritis Rheum. 2003 Jun;48(6):1484-92. doi: 10.1002/art.10947.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / immunology
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • B-Lymphocytes / drug effects*
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / immunology
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / immunology
  • Mice
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / therapeutic use
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Recombinant Fusion Proteins
  • Rituximab